Tag: HER2

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to HER2

AstraZeneca, Daiichi Sankyo's Enhertu recommended for approval in EU - TipRanks.com

Added to Collection on: 2025-02-28 15:56:32

Tags for this article:

Orphan drugs
Antineoplastic drugs
Antibody-drug conjugates
Immunology
Daiichi Sankyo
Trastuzumab deruxtecan
AstraZeneca
HER2
Durvalumab
Trastuzumab
Breast cancer
Antibody-drug conjugate

Click the tags to see associated articles and topics

View Article Details
AstraZeneca breast cancer therapy wins recommendation for EU approval - Morningstar

Added to Collection on: 2025-02-28 15:37:57

Tags for this article:

Antibody-drug conjugates
Orphan drugs
Immunology
Daiichi Sankyo
Trastuzumab deruxtecan
Breast cancer
HER2
AstraZeneca
Trastuzumab
Antibody-drug conjugate
Dalpiciclib
TOKYO
AstraZeneca plc
Daiichi Sankyo Co Ltd

Click the tags to see associated articles and topics

View Article Details
Identification of M1 macrophage infiltration-related genes for immunotherapy in Her2 ... - Nature

Added to Collection on: 2025-04-11 20:37:13

Tags for this article:

Immune system
Clusters of differentiation
T cells
Immunology
Breast cancer
HER2
Regulatory T cell
FOXP3
Immune checkpoint
PD-L1
Programmed cell death protein 1
Checkpoint inhibitor

Click the tags to see associated articles and topics

View Article Details
Machine learning prediction of HER2-low expression in breast cancers based on ...

Added to Collection on: 2025-04-18 13:14:15

Tags for this article:

Breast cancer
Cancer treatments
HER2
Oncogenes
Predictive marker
Trastuzumab
Triple-negative breast cancer

Click the tags to see associated articles and topics

View Article Details
AstraZeneca, Daiichi Sankyo Push Enhertu to Frontline Breast Cancer With Phase III Data

Added to Collection on: 2025-04-22 12:36:11

Tags for this article:

Antineoplastic drugs
Immunology
Antibody-drug conjugates
Orphan drugs
Daiichi Sankyo
Trastuzumab deruxtecan
Antibody-drug conjugate
Pertuzumab
AstraZeneca
HER2
Trastuzumab
Breast cancer

Click the tags to see associated articles and topics

View Article Details
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results

Added to Collection on: 2025-04-25 14:28:10

Tags for this article:

Breast cancer
Cancer treatments
Immunology
Chloroarenes
Neratinib
Nitriles
HER2
Trastuzumab
Puma Biotechnology
Oncology
Trastuzumab emtansine
Xavier Pivot

Click the tags to see associated articles and topics

View Article Details
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting

Added to Collection on: 2025-04-26 05:06:19

Tags for this article:

Immunology
Antibody-drug conjugate
Cancer immunotherapy
Cofetuzumab pelidotin
Antibody
Bi-specific T-cell engager
Monoclonal antibody therapy
PTK7
Bispecific monoclonal antibody
HER2
Sotio
Sutro Biopharma
ZYMEWORKS INC

Click the tags to see associated articles and topics

View Article Details
Enhertu Shows Promise as First-Line Treatment for Metastatic Breast Cancer

Added to Collection on: 2025-04-29 19:50:53

Tags for this article:

Antineoplastic drugs
Immunology
Antibody-drug conjugates
Orphan drugs
Breast cancer
Pertuzumab
Trastuzumab deruxtecan
Antibody-drug conjugate
Trastuzumab
HER2
AstraZeneca
Trastuzumab emtansine

Click the tags to see associated articles and topics

View Article Details
EMA Committee recommends EU label update for Roche Phesgo to allow administration ...

Added to Collection on: 2025-05-04 08:01:35

Tags for this article:

Antineoplastic drugs
Cancer treatments
Pertuzumab
Trastuzumab
HER2
Breast cancer
Trastuzumab emtansine
Genentech

Click the tags to see associated articles and topics

View Article Details
Targeted Therapeutics Market To Hit USD 152.9 Bn By 2033

Added to Collection on: 2025-05-06 06:29:21

Tags for this article:

Oncogenes
Biotechnology
Cancer
Biomarkers
Chemical pathology
Targeted therapy
Personalized medicine
Oncology
Breast cancer
HER2
KRAS
Non-small-cell lung cancer

Click the tags to see associated articles and topics

View Article Details
Book a Demo